About LNX

2026

2025

2024

2023

2022

2021

2020

2019

  • 2026-3

    Exhibition at CACLP Xiamen: Solid-State Nanopore Single-Molecule Detector Makes Grand Debut, Leading Precision Testing into the Handheld Era

  • 2026-5

    Shortlisted for Suzhou Innovation Consortium Project; Co-established Cutting-edge Solid-state Nanopore Laboratory with Tsinghua University, Southeast University, North University of China and Linyi University

  • 2026-6

    Cooperate with Zhonghe Gene to Build Synthetic Biology Layout Featuring "Free Synthesis & Free Detection" for Industrial Quality Control Applications

  • 2026-6

    Helicobacter Pylori (HP) Antigen Detection Kit (Colloidal Gold Immunochromatography) Obtained Class III Medical Device Registration Certificate

  • 2025-6

    Establishment of Linaxin Beijing Office

  • 2025-7

    Changlexin Obtains Registration Approval from India's CDSCO

  • 2025-10

    Clinical Trials of H. pylori Product Completed, Registration Application Submitted

  • 2025-11

    Global Launch of Linaxin 4th-Generation Solid-State Nanopore Genetic Analyzer

  • 2025-12

    Registration Clinical Trials of Lichangqing for Fecal DNA Methylation Detection of Colorectal Cancer Launched

  • 2024-3

    Registration Testing of Lichangqing, the Company's Product, Completed

  • 2024-4

    Acceptance Inspection of Linaxin's Second Medical Laboratory Center

  • 2024-4

    Launch of Registration Clinical Trials for You'anxin (Helicobacter Pylori Test Product)

  • 2024-5

    Completion Signing of the Company's New Round of Equity Financing

  • 2024-9

    Linaxin Successfully Selected as a Potential Unicorn Enterprise of Jiangsu 2024

  • 2024-11

    Completed Multi-Ten-Million-Yuan Series A Financing

  • 2024-12

    Linaxin Certified as a National High-tech Enterprise in 2024

  • 2024-12

    Linaxin (Linyi) Medical Laboratory Center Officially Opens for Operation

  • 2023-2

    Becoming an executive director unit of the China Medical Supplies Association

  • 2023-3

    The fourth generation solid-state nanopore gene detector Lsmart-SP1 prototype has been released

  • 2023-7

    Convene the Fourth United Dream Building Development Conference

  • 2022-1

    Changweile ™ Approved National Class II Medical Device Registration Certificate

  • 2022-4

    Shandong Binzhou Yellow River Ballad Medical Laboratory officially starts operation

  • 2022-5

    Lichang Qing ® Complete the filing of Class I medical devices

  • 2022-6

    Colorectal cancer early screening series products Li Changsheng ®、 Lichang Qing ® Entering the market with LDT

  • 2022-8

    The company has completed millions of financing for Pre-A

  • 2021-4

    Li Changsheng ® Complete the preparation of Class I medical devices

  • 2021-12

    Changle Xin ® Approved National Class II Medical Device Registration Certificate

  • 2020-7~2020-9

    Lixin Nuokang production base has been established and put into use in the Yinan Innovation and Entrepreneurship Park in Shandong Province

  • 2019-7

    Suzhou Linaxin officially established